These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 10384246)
1. Inhibitors of human immunodeficiency virus integrase. Pommier Y; Neamati N Adv Virus Res; 1999; 52():427-58. PubMed ID: 10384246 [TBL] [Abstract][Full Text] [Related]
2. Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore. Kehlenbeck S; Betz U; Birkmann A; Fast B; Göller AH; Henninger K; Lowinger T; Marrero D; Paessens A; Paulsen D; Pevzner V; Schohe-Loop R; Tsujishita H; Welker R; Kreuter J; Rübsamen-Waigmann H; Dittmer F J Virol; 2006 Jul; 80(14):6883-94. PubMed ID: 16809294 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells. Hazuda DJ; Felock P; Witmer M; Wolfe A; Stillmock K; Grobler JA; Espeseth A; Gabryelski L; Schleif W; Blau C; Miller MD Science; 2000 Jan; 287(5453):646-50. PubMed ID: 10649997 [TBL] [Abstract][Full Text] [Related]
4. Effect of DNA modifications on DNA processing by HIV-1 integrase and inhibitor binding: role of DNA backbone flexibility and an open catalytic site. Johnson AA; Sayer JM; Yagi H; Patil SS; Debart F; Maier MA; Corey DR; Vasseur JJ; Burke TR; Marquez VE; Jerina DM; Pommier Y J Biol Chem; 2006 Oct; 281(43):32428-38. PubMed ID: 16943199 [TBL] [Abstract][Full Text] [Related]
5. HIV integrase as a target for antiviral chemotherapy. Nair V Rev Med Virol; 2002; 12(3):179-93. PubMed ID: 11987143 [TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationships of HIV-1 integrase inhibitors--enzyme-ligand interactions. Maurin C; Bailly F; Cotelle P Curr Med Chem; 2003 Sep; 10(18):1795-810. PubMed ID: 12871105 [TBL] [Abstract][Full Text] [Related]
7. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods. Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375 [TBL] [Abstract][Full Text] [Related]
8. Discovery of a nuclease-resistant, non-natural dinucleotide that inhibits HIV-1 integrase. Taktakishvili M; Neamati N; Pommier Y; Nair V Bioorg Med Chem Lett; 2001 Jun; 11(11):1433-5. PubMed ID: 11378371 [TBL] [Abstract][Full Text] [Related]
9. Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targets. Chen IJ; Neamati N; Nicklaus MC; Orr A; Anderson L; Barchi JJ; Kelley JA; Pommier Y; MacKerell AD Bioorg Med Chem; 2000 Oct; 8(10):2385-98. PubMed ID: 11058033 [TBL] [Abstract][Full Text] [Related]
10. Structure and function of HIV-1 integrase. Chiu TK; Davies DR Curr Top Med Chem; 2004; 4(9):965-77. PubMed ID: 15134551 [TBL] [Abstract][Full Text] [Related]
11. Targeting HIV-1 integrase with strand transfer inhibitors. Li Y; Xuan S; Feng Y; Yan A Drug Discov Today; 2015 Apr; 20(4):435-49. PubMed ID: 25486307 [TBL] [Abstract][Full Text] [Related]
12. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase. Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the HIV-1 integrase core domain in complex with sucrose reveals details of an allosteric inhibitory binding site. Wielens J; Headey SJ; Jeevarajah D; Rhodes DI; Deadman J; Chalmers DK; Scanlon MJ; Parker MW FEBS Lett; 2010 Apr; 584(8):1455-62. PubMed ID: 20227411 [TBL] [Abstract][Full Text] [Related]
14. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches. Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161 [TBL] [Abstract][Full Text] [Related]
15. Novel inhibitors of HIV-1 integration. Witvrouw M; Van Maele B; Vercammen J; Hantson A; Engelborghs Y; De Clercq E; Pannecouque C; Debyser Z Curr Drug Metab; 2004 Aug; 5(4):291-304. PubMed ID: 15320701 [TBL] [Abstract][Full Text] [Related]
16. Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1. Cherepanov P; Esté JA; Rando RF; Ojwang JO; Reekmans G; Steinfeld R; David G; De Clercq E; Debyser Z Mol Pharmacol; 1997 Nov; 52(5):771-80. PubMed ID: 9351967 [TBL] [Abstract][Full Text] [Related]
17. Identification of a small-molecule binding site at the dimer interface of the HIV integrase catalytic domain. Molteni V; Greenwald J; Rhodes D; Hwang Y; Kwiatkowski W; Bushman FD; Siegel JS; Choe S Acta Crystallogr D Biol Crystallogr; 2001 Apr; 57(Pt 4):536-44. PubMed ID: 11264582 [TBL] [Abstract][Full Text] [Related]
19. Interaction of HIV-1 integrase with polypyrimidine tract binding protein and associated splicing factor (PSF) and its impact on HIV-1 replication. Yadav P; Sur S; Desai D; Kulkarni S; Sharma V; Tandon V Retrovirology; 2019 Apr; 16(1):12. PubMed ID: 31036027 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 integrase-catalysed reaction by new DNA minor groove ligands: the oligo-1,3-thiazolecarboxamide derivatives. Ryabinin VA; Sinyakov AN; de Soultrait VR; Caumont A; Parissi V; Zakharova OD; Vasyutina EL; Yurchenko E; Bayandin R; Litvak S; Tarrago-Litvak L; Nevinsky GA Eur J Med Chem; 2000 Nov; 35(11):989-1000. PubMed ID: 11137227 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]